Learn how EHR treatment plans and clinical pathways are leveraged to prefer or restrict access to different products.
Our panel will explore different platforms and EHR systems to help manufacturers better understand how community and academic oncology providers “manage” drug regimens.
Specifically – we discuss how cancer centers utilize subscribed pathways such as ClinPath & ValuePathways, internally developed pathways, or no Provider pathway at all.
We will explore how regimens are positioned on EHR order sets to create “favorites” or limit access to other regimens.
Don’t miss your opportunity to hear from the experts.
